Skip Nav Destination
Issues
September 2010
ISSN 0378-584X
EISSN 1423-0240
Journal Name Change
Continued with Vol. 37 (2014) as: Oncology Research and Treatment.
Onkologie 2010, Vol. 33, No. 8-9
Editorial Board
Editorial Board
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 413.
https://doi.org/10.1159/000321029
Contents · Inhalt
Editorial
Using Anti-Cancer Agents during the Post-Partum Period: Not that Simple
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 419.
https://doi.org/10.1159/000318794
Trastuzumab as Single Agent Therapy for HER2-Positive Metastatic Breast Cancer
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 420–421.
https://doi.org/10.1159/000318991
Original Article · Originalarbeit
Trastuzumab Single-Drug Therapy after Failure of Cytotoxic Treatment for Metastatic Breast Cancer
Subject Area:
Oncology
Michael Clemens; Holger Eidtmann; Ulrike Nitz; Norbert Niederle; Andreas du Bois; Eva-Maria Grischke; Axel Hinke; Gunter von Minckwitz
Onkologie (2010) 33 (8-9): 425–430.
https://doi.org/10.1159/000318144
Clinical Study of Adjuvant Capecitabine Monotherapy in Chinese Elderly Patients (Aged 55–70) with Stage IIa Breast Cancer
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 433–436.
https://doi.org/10.1159/000317267
Annexin and Survivin in Locally Advanced Rectal Cancer: Indicators of Resistance to Preoperative Chemoradiotherapy?
Subject Area:
Oncology
Karoline Horisberger; Philipp Erben; Philipp Ströbel; Beatrice Bohn; Melanie Hahn; Georg Kähler; Frederik Wenz; Andreas Hochhaus; Stefan Post; Frank Willeke; Ralf-Dieter Hofheinz; on behalf of the Mannheimer Arbeitsgruppe für Gastrointestinale Tumoren (MARGIT)
Onkologie (2010) 33 (8-9): 439–444.
https://doi.org/10.1159/000318145
Long-Term Renal Safety Profile of Ibandronate 6 mg Infused over 15 Minutes
Subject Area:
Oncology
Roger von Moos; Clemens B. Caspar; Rolf Steiner; Rahel Angst; Roman Inauen; Kerstin Schmieding; Beat Thürlimann
Onkologie (2010) 33 (8-9): 447–450.
https://doi.org/10.1159/000317256
Case Report · Kasuistik
Paraneoplastic Limbic Encephalitis in a Patient with Extragonadal Choriocarcinoma – Significance of Onconeural Antibodies
Subject Area:
Oncology
Joanna Szkandera; Ferdin Ploner; Thomas Bauernhofer; Anne-Katrin Kasparek; Franz Payer; Marija Balic; Gudrun Knechtel; Armin Gerger; Günter Gallè; Hellmut Samonigg; Günter Hofmann
Onkologie (2010) 33 (8-9): 452–454.
https://doi.org/10.1159/000317269
Nonbacterial Thrombotic (Marantic) Endocarditis in a Patient with Colorectal Cancer
Subject Area:
Oncology
Panagiotis J. Vlachostergios; Danai D. Daliani; Vassilis Dimopoulos; Anna Patrikidou; Ioannis A. Voutsadakis; Christos N. Papandreou
Onkologie (2010) 33 (8-9): 456–459.
https://doi.org/10.1159/000317342
Burkitt’s Lymphoma in Pregnancy with Bilateral Breast Involvement: Case Report with Review of the Literature
Subject Area:
Oncology
Paraskevi Savvari; Chara Matsouka; Despoina Barbaroussi; Dimitrios Christoulas; Nikitas Nikitas; Meletios-A. Dimopoulos; Christos A. Papadimitriou
Onkologie (2010) 33 (8-9): 461–464.
https://doi.org/10.1159/000317344
Restoration of Gefitinib Efficacy Following Chemotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 466–469.
https://doi.org/10.1159/000319109
Review Article · Übersichtsarbeit
Management of the Cutaneous Side Effects of Therapeutic Epidermal Growth Factor Receptor Inhibition
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 470–479.
https://doi.org/10.1159/000317132
Letter to the Editors · Brief an die Herausgeber
Ovarian Metastasis of a Lymphoma
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 480.
https://doi.org/10.1159/000317364
Further Section · Weitere Sektionen
PharmaForum
ASCO 2010: Stellenwert von Sunitinib und Temsirolimus bestätigt mRCC-Patienten profitieren vonLangzeittherapie mit Sunitinib
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 483.
https://doi.org/10.1159/000321022
Leptomeningeale Metastasen bei hämatologischen Neoplasien: Liposomales Cytarabin zeigt hohes Potenzial zur Therapieoptimierung
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 484–485.
https://doi.org/10.1159/000321023
Further Section · Weitere Sektionen
PharmaNews / PharmaTicker
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 487–489.
https://doi.org/10.1159/000321024
Meetings and Conferences · Tagungen und Kongresse
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 490–491.
https://doi.org/10.1159/000321025
Contents of Forthcoming Issues · Themenvorschau
Subject Area:
Oncology
Onkologie (2010) 33 (8-9): 492.
https://doi.org/10.1159/000321026
